目的：测定复方熊胆乙肝胶囊中熊去氧胆酸的含量。
Objective: To determine the content ursodesoxycholic acid of Compound Capsule of Bear Gall thylic.
熊去氧胆酸是一种亲水性胆汁酸，能阻止疏水性胆汁酸的细胞毒作用，抑制细胞毒T细胞(CTL)对靶细胞的攻击作用。
Ursodeoxycholic acid is a kind of hydrophilic bile acid. It can hinder hydrophobic bile acid from its hepatotoxicity to liver and the damage of cytotoxic t lymphocyte (CTL) to its target cells.
药物多推荐熊去氧胆酸，但效果欠佳。
Medical therapy has recommended ursodeoxycholic acid, however, the effect is not good enough.
熊去氧胆酸（UDCA）是惟一经随机对照临床试验证实的治疗PBC安全有效的药物。
Ursodeoxycholic acid (UDCA) is the only safe and effective drug for the treatment of PBC proven by randomized controlled clinical trials.
方法将80只豚鼠随机分为4组，分别为空白组、致石组、熊胆粉预防组、熊去氧胆酸(UDCA)预防组。
Methods Totally 80 guinea pigs randomly divided into 4 groups i. e. blank group, lithogenic group, prevention by bear bile powder group and UDCA group.
目的：建立以反相高效液相色谱法测定熊去氧胆酸胶囊中熊去氧胆酸含量的方法。
OBJECTIVE: To determine the content of Ursodeoxycholic acid in Ursodeoxycholic acid capsules by RP-HPLC.
目的 ：测定复方熊胆乙肝胶囊中熊去氧胆酸的含量。
OBJECTIVE: To determine the content of Ursodeoxycholic acid in Ursodeoxycholic acid capsules by RP-HPLC.
结论 保胆取石术后患者口服牛磺熊去氧胆酸对胆囊结石的复发有预防作用。
Objective To evaluate the clinical application value of the tauro ursodeoxycholic acid (TUDCA) for preventing the relapse of lithiasis after the gallbladder-protected lithotomy.
结论 保胆取石术后患者口服牛磺熊去氧胆酸对胆囊结石的复发有预防作用。
Objective To evaluate the clinical application value of the tauro ursodeoxycholic acid (TUDCA) for preventing the relapse of lithiasis after the gallbladder-protected lithotomy.
应用推荐